132 related articles for article (PubMed ID: 7859416)
1. Longitudinal study of anticentromere and antitopoisomerase-I isotypes.
Vázquez-Abad D; Russell CA; Cusick SM; Earnshaw WC; Rothfield NF
Clin Immunol Immunopathol; 1995 Mar; 74(3):257-70. PubMed ID: 7859416
[TBL] [Abstract][Full Text] [Related]
2. Anticentromere autoantibodies in patients without Raynaud's disease or systemic sclerosis.
Vázquez-Abad D; Grodzicky T; Senécal JL
Clin Immunol; 1999 Feb; 90(2):182-9. PubMed ID: 10080829
[TBL] [Abstract][Full Text] [Related]
3. A cross-reactive idiotype in scleroderma.
Vázquez-Abad D; Tian L; Zanetti M; Rothfield NF
Clin Exp Immunol; 1997 Jun; 108(3):420-7. PubMed ID: 9182886
[TBL] [Abstract][Full Text] [Related]
4. Cytogenetic survey in systemic sclerosis: correlation of aneuploidy with the presence of anticentromere antibodies.
Jabs EW; Tuck-Muller CM; Anhalt GJ; Earnshaw W; Wise RA; Wigley F
Cytogenet Cell Genet; 1993; 63(3):169-75. PubMed ID: 8387418
[TBL] [Abstract][Full Text] [Related]
5. Idiotypic analysis of human anticentromere autoantibodies.
Hildebrandt S; Weiner ES; Earnshaw WC; Zanetti M; Rothfield NF
Autoimmunity; 1991; 9(2):131-40. PubMed ID: 1657226
[TBL] [Abstract][Full Text] [Related]
6. Anticentromere-protein-B--DNA complex activities in anticentromere antibody-positive patients.
Muro Y; Matsumoto Y; Ohashi M
Arch Dermatol Res; 1992; 284(7):396-9. PubMed ID: 1288420
[TBL] [Abstract][Full Text] [Related]
7. Proteins responsible for anticentromere activity found in the sera of patients with CREST-associated Raynaud's phenomenon.
Kremer L; Alvaro-Gracia JM; Ossorio C; Avila J
Clin Exp Immunol; 1988 Jun; 72(3):465-9. PubMed ID: 3048807
[TBL] [Abstract][Full Text] [Related]
8. The IgG, IgM, and IgA isotypes of anti-topoisomerase I and anticentromere autoantibodies.
Hildebrandt S; Weiner E; Senécal JL; Noell S; Daniels L; Earnshaw WC; Rothfield NF
Arthritis Rheum; 1990 May; 33(5):724-7. PubMed ID: 2161233
[TBL] [Abstract][Full Text] [Related]
9. Anti-CENP-B response in sera of uranium miners exposed to quartz dust and patients with possible development of systemic sclerosis (scleroderma).
Conrad K; Stahnke G; Liedvogel B; Mehlhorn J; Barth J; Blasum C; Altmeyer P; Sönnichsen N; Frank KH
J Rheumatol; 1995 Jul; 22(7):1286-94. PubMed ID: 7562760
[TBL] [Abstract][Full Text] [Related]
10. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
Russo K; Hoch S; Dima C; Varga J; Teodorescu M
J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
[TBL] [Abstract][Full Text] [Related]
11. Immunoblotting on HEp-2 cells increases the detection of antitopoisomerase 1 antibodies in patients with systemic sclerosis.
Tamby MC; Servettaz A; Guilpain P; Tamas N; Berezné A; Batteux F; Reinbolt J; Guillevin L; Weill B; Mouthon L
Clin Immunol; 2007 Apr; 123(1):82-8. PubMed ID: 17258939
[TBL] [Abstract][Full Text] [Related]
12. Anticentromere autoantibodies. Evaluation of an ELISA using recombinant fusion protein CENP-B as antigen.
Vázquez-Abad D; Wallace S; Senécal JL; Joyal F; Roussin A; Earnshaw WC; Rothfield N
Arthritis Rheum; 1994 Feb; 37(2):248-52. PubMed ID: 8129780
[TBL] [Abstract][Full Text] [Related]
13. Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components Analysis.
Patterson KA; Roberts-Thomson PJ; Lester S; Tan JA; Hakendorf P; Rischmueller M; Zochling J; Sahhar J; Nash P; Roddy J; Hill C; Nikpour M; Stevens W; Proudman SM; Walker JG
Arthritis Rheumatol; 2015 Dec; 67(12):3234-44. PubMed ID: 26246178
[TBL] [Abstract][Full Text] [Related]
14. Isotype analysis of the anti-CENP-B anticentromere autoantibody: evidence for restricted clonality.
Eisenberg RA; Earnshaw WC; Bordwell BJ; Craven SY; Cheek R; Rothfield NF
Arthritis Rheum; 1989 Oct; 32(10):1315-8. PubMed ID: 2508644
[TBL] [Abstract][Full Text] [Related]
15. The clinical expression in anticentromere antibody-positive patients is not specified by the epitope recognition of CENP-B antigen.
Muro Y; Sugimoto K; Himeno M; Ohashi M
J Dermatol; 1992 Oct; 19(10):584-91. PubMed ID: 1283396
[TBL] [Abstract][Full Text] [Related]
16. Anti-centromere antibodies in a large cohort of systemic sclerosis patients: comparison between immunofluorescence, CENP-A and CENP-B ELISA.
Mahler M; You D; Baron M; Taillefer SS; Hudson M; ; Fritzler MJ
Clin Chim Acta; 2011 Oct; 412(21-22):1937-43. PubMed ID: 21756890
[TBL] [Abstract][Full Text] [Related]
17. A case of systemic sclerosis with anticentromere, antitopoisomerase I, and anti-U1RNP antibodies.
Sato S; Ihn H; Soma Y; Shimozuma M; Shishiba T; Takehara K
J Rheumatol; 1993 Nov; 20(11):1961-3. PubMed ID: 8308786
[TBL] [Abstract][Full Text] [Related]
18. Anti-CENP-B and anti-TOPO-1-containing sera from systemic sclerosis-related diseases with Raynaud's phenomenon induce vascular endothelial cell senescence not via classical p53-p21 pathway.
Shen CY; Li KJ; Lai PH; Yu CL; Hsieh SC
Clin Rheumatol; 2018 Mar; 37(3):749-756. PubMed ID: 28940121
[TBL] [Abstract][Full Text] [Related]
19. Three human chromosomal autoantigens are recognized by sera from patients with anti-centromere antibodies.
Earnshaw W; Bordwell B; Marino C; Rothfield N
J Clin Invest; 1986 Feb; 77(2):426-30. PubMed ID: 3511098
[TBL] [Abstract][Full Text] [Related]
20. CENP-O, a protein localized at the centromere throughout the cell cycle, is a novel target antigen in systemic sclerosis.
Saito A; Muro Y; Sugiura K; Ikeno M; Yoda K; Tomita Y
J Rheumatol; 2009 Apr; 36(4):781-6. PubMed ID: 19286853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
